Valuation Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq 04:00:00 12/09/2026 HKT			5-day change	1st Jan Change
32.47 ^USD	+0.74%		-3.36%	+5.42%

09-08	Espiria Hållbar Framtid rose 4.5 percent in August, Vestas and Hansa Biopharma made positive contributions	FW
09-08	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	172,063	192,229	140,770	94,810	124,862	125,006	-	-
Change	-	11.72%	-26.77%	-32.65%	31.7%	0.12%	-	-
Enterprise Value (EV) ¹	152,725	169,905	112,635	73,709	114,029	144,178	136,015	123,218
Change	-	11.25%	-33.71%	-34.56%	54.7%	26.44%	-5.66%	-9.41%
P/E	57.8x	35.2x	32.6x	12.3x	20.9x	26.5x	18.6x	12.5x
PBR	7.82x	7.07x	4.5x	2.68x	3.47x	3.12x	2.66x	2.2x
PEG	-	0.4x	-1.5x	0.1x	-1x	-1.4x	0.4x	0.3x
Capitalization / Revenue	20.3x	13.2x	8.54x	4.4x	5.31x	4.32x	3.71x	3.07x
EV / Revenue	18x	11.6x	6.84x	3.42x	4.85x	4.98x	4.03x	3.02x
EV / EBITDA	46.8x	25.3x	20.1x	10.4x	15.9x	16.6x	10.9x	7.18x
EV / EBIT	50.6x	26.7x	21.2x	10.5x	17x	18.7x	13.4x	8.66x
EV / FCF	77.3x	47.3x	16.1x	9.72x	15.7x	24.1x	17.7x	10.4x
FCF Yield	1.29%	2.12%	6.23%	10.3%	6.36%	4.15%	5.64%	9.66%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	45.54	83.65	66.02	121.4	97.08	79.08	112.4	167.5
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	8,482	14,595	16,474	21,526	23,497	28,951	33,716	40,736
EBITDA ¹	3,266	6,719	5,616	7,116	7,175	8,705	12,462	17,161
EBIT ¹	3,018	6,357	5,321	7,003	6,727	7,726	10,124	14,222
Net income ¹	3,008	5,522	4,352	7,844	6,083	4,929	7,163	10,665
Net Debt ¹	-19,338	-22,324	-28,135	-21,101	-10,833	19,173	11,009	-1,788
Reference price ²	2,630.00	2,941.00	2,155.00	1,492.50	2,027.00	2,092.00	2,092.00	2,092.00
Nbr of stocks (in thousands)	65,423	65,362	65,322	63,524	61,599	59,754	-	-
Announcement Date	16/2/22	22/2/23	14/2/24	12/2/25	17/2/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	19.64x	6.93x	13.92x	1.51%	66.93B
ARGENX SE	31.94x	9.24x	44.54x	0.04%	61.97B
INSMED INCORPORATED	-79.21x	15.29x	-73.77x	-.--%	28.26B
WUXI BIOLOGICS (CAYMAN) INC.	28.46x	6.03x	15.64x	-.--%	24.59B
BIONTECH SE	-14.63x	5.3x	-6.66x	-.--%	24.3B
GENMAB A/S	26.45x	4.98x	16.56x	-.--%	19.41B
PHARMAESSENTIA CORPORATION	48.28x	17.79x	36.09x	0.31%	16.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1225.47x	35.26x	769.42x	-.--%	14.18B
SUMMIT THERAPEUTICS INC.	-15x	3382.33x	-17.29x	-.--%	14B
Average	141.27x	387.02x	88.72x	0.21%	30.05B
Weighted average by Cap.	73.54x	184.88x	49.64x	0.4%